XML 46 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of the Company’s share-based compensation expense for the three months ended March 31, 2026 and 2025 are as follows:
Three Months Ended March 31,
20262025
(in thousands)
Stock options$295 $1,568 
Restricted stock units and deferred stock units1,869 1,765 
Performance stock units514 352 
Employee Stock Purchase Plan86 53 
Total share-based compensation expense$2,764 $3,738 
The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and 2025:

Three Months Ended March 31,
20262025
(in thousands)
Selling, general and administrative expense$2,742 $3,724 
Costs of services provided22 14 
Total share-based compensation expense$2,764 $3,738 
Schedule of Stock Options Outstanding
A summary of stock options outstanding under the Amended 2020 Plan and the 2012 Plan as of December 31, 2025 and changes during the three months ended March 31, 2026 are as follows:
Stock Options Outstanding
Number of SharesWeighted Average Exercise Price
(in thousands)
December 31, 20252,486 $25.99 
Granted— $— 
Exercised(91)$15.91 
Forfeited— $— 
Expired(299)$34.21 
March 31, 20262,096 $25.25 
Schedule of Assumption for Fair Value of Options Granted
There were no stock option awards granted during the three months ended March 31, 2026. The fair value of stock option awards granted during the three months ended March 31, 2025 was estimated on the dates of grant using the Black-Scholes option valuation model with the following assumptions:
2025
Risk-free interest rate4.5 %
Weighted average expected life7.2 years
Expected volatility42.1 %
Dividend yield— %
Schedule of Other Information about Stock Options
The following table summarizes other information about the stock options at March 31, 2026:
March 31, 2026
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$5,121 
Weighted average remaining contractual life4.9 years
Exercisable:
Number of options1,555 
Weighted average exercise price$29.73 
Aggregate intrinsic value$1,803 
Weighted average remaining contractual life3.9 years
Schedule of Outstanding Restricted Stock Units
A summary of the outstanding RSUs and DSUs as of December 31, 2025 and changes during the three months ended March 31, 2026 is as follows:
Restricted Stock Units & Deferred Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 20251,791 $12.68 
Granted474 $18.08 
Vested(471)$14.03 
Forfeited(16)$13.41 
March 31, 20261,778 $13.75 
Schedule of Outstanding Performance Stock Units
A summary of the outstanding PSUs as of December 31, 2025 and changes during the three months ended March 31, 2026 is as follows:

Performance Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 2025304 $14.00 
Granted186 $21.12 
Vested(108)$16.20 
Forfeited— $— 
March 31, 2026382 $16.84 
Schedule of Options Granted Under Employee Stock Purchase Plan
The expense associated with the options granted under the ESPP during the three months ended March 31, 2026 and 2025 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
Three Months Ended March 31,
20262025
Risk-free interest rate3.5%4.2%
Weighted average expected life (years)1.01.0
Expected volatility43.9%39.3%
Dividend yield—%—%
Schedule of Supplemental Employee Retirement Plan
The following table summarizes information about the SERP during the three months ended March 31, 2026 and 2025:
Three Months Ended March 31,
 20262025
(in thousands)
SERP expense loss1
$186 $191 
Unrealized loss recorded in SERP liability account$(1,570)$(1,467)
1.Both the SERP match and the deferrals are included in the “Selling, general and administrative expense” caption in the Consolidated Statements of Comprehensive Income.